Nuvalent, Inc.
Biotechnology ResearchView the employees at
Nuvalent, Inc.-
Nathan McConarty Assistant General Counsel, Corporate & Securities at Nuvalent
-
Top 5%
sapna srivastava Board Member at Aura Biosciences-
New York, New York, United States
-
Top 10%
Emily Drabant Conley Biotech CEO, Board Member-
San Francisco Bay Area
-
Rising Star
Chris Cooper Director of Process Chemistry at Nuvalent-
Greater Boston
-
Rising Star
Paige McCauley-Goodman Senior Manager, GCP QA at Nuvalent, Inc.-
Dorchester, Massachusetts, United States
-
Rising Star
Overview
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. To learn more, visit www.nuvalent.com.
-